Thoracic Cancer中国作者高被引论文集锦(2020)
热烈祝贺Thoracic Cancer 在最新发布的2020年度JCR中影响因子上升至3.500,位列呼吸系统学科类期刊Q2区、肿瘤学科类期刊Q3区!近期,小编基于2020年发表文章的被引用数据遴选出了中国作者高被引论文Top10,所有论文皆可免费阅读和下载。
1. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis
2. Environmental pollutants damage airway epithelial cell cilia: Implications for the prevention of obstructive lung diseases
3. CircRNA CDR1 as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis
4. Application of electrochemical biosensors in tumor cell detection
5. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p
环状RNA(circRNA)已被证实是人类癌症(包括乳腺癌)化学抗性的关键调节因子。在此项研究中,研究人员探索了circ-RNF111在乳腺癌紫杉醇 (PTX) 抗性中的作用。他们首先采用定量实时聚合酶链反应 (qRT-PCR) 并且建立小鼠异种移植模型以研究 circ-RNF111相关的表达以及其作用。之后进行双荧光素酶报告基因测定和 RNA 免疫沉淀 (RIP) 测定以验证各变量之间的关系。最后进行蛋白质印迹测定以检查E2F3的蛋白质水平。最终验证了Circ-RNF111 通过海绵 miR-140-5p 上调 E2F3 来改善乳腺癌的 PTX 抗性。
6. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples
7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis
Wenlong He, Yeying Zhang, Shulan Xia
。研究表明,长链非编码 RNA 烟酰胺核苷酸转氢酶-反义RNA1 (NNT-AS1) 在大多数恶性肿瘤中起到致癌基因的作用,包括非小细胞肺癌 (NSCLC)。本研究证实了NNT-AS1 可以通过吸附 miR-22-3p 和调节 YAP1 表达促进 NSCLC 细胞的增殖、迁移、侵袭和上皮细胞向间充质细胞转化,这可能为 NSCLC 提供了一个潜在的生物标志物和治疗靶点。
8. Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic
9. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events
10. Review: The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs)
关于期刊
翻译 | 郭文哲,力二,Amanda等
校对 | Jiayi
排版 | Amanda
最新评论
推荐文章
作者最新文章
你可能感兴趣的文章
Copyright Disclaimer: The copyright of contents (including texts, images, videos and audios) posted above belong to the User who shared or the third-party website which the User shared from. If you found your copyright have been infringed, please send a DMCA takedown notice to [email protected]. For more detail of the source, please click on the button "Read Original Post" below. For other communications, please send to [email protected].
版权声明:以上内容为用户推荐收藏至CareerEngine平台,其内容(含文字、图片、视频、音频等)及知识版权均属用户或用户转发自的第三方网站,如涉嫌侵权,请通知[email protected]进行信息删除。如需查看信息来源,请点击“查看原文”。如需洽谈其它事宜,请联系[email protected]。
版权声明:以上内容为用户推荐收藏至CareerEngine平台,其内容(含文字、图片、视频、音频等)及知识版权均属用户或用户转发自的第三方网站,如涉嫌侵权,请通知[email protected]进行信息删除。如需查看信息来源,请点击“查看原文”。如需洽谈其它事宜,请联系[email protected]。